Commentary: Inflammation, Demyelination and Neurodegeneration: Risky Buddies in Multiple Sclerosis. Amadio S, Volonté C CNS Neurol Disord Drug Targets. 2013 Sep 18. PMID: 24059312. Abstract CommentRecommendBookmarkWatch